We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Information on authorised vaccines and vaccination schedules for dogs.
How to submit an application, data package and responses for proposed or existing marketing authorisations.
How to apply for an authorisation to manufacture authorised veterinary medicines or medicines marketed under the Exemptions for small pet animals.
Apply for an authorisation to manufacture extemporaneous preparations, autogenous vaccines, stem cell products or blood products for non-food animals.
Reported problems with the supply of an animal medicine and the date when the issue is expected to be resolved.
Explainer for the pharmaceutical industry on the implementation of Pharmacovigilance requirements during the transition time from the date the revised VMR have effect in GB to 17 May 2027.
Summary of product characteristics for BLUEVAC-3 BTV-3 vaccine in the UK
Guidance for the veterinary pharmaceutical industry on the production and submission of the Summary of Product Characteristics (SPCs) and product literature mock-ups.
This enforcement policy sets out the general principles and approach taken by the VMD.
Requirement to analyse samples from food producing animals for residues of veterinary medicines and prohibited substances.
Legal requirements referred to in Schedule 1 of the Veterinary Medicines Regulations, as amended.
Effective from 17 May 2024 Definitive fees charged for applications under Schedule 7 of Veterinary Medicines Regulations 2013 (as amended) as they apply to GB.
All national applications will be processed on one of six timetables that vary in length depending on the complexity and nature of the application under assessment.
Canada and UK Trade Continuity Agreement enters into force
Legal requirements for the sale of veterinary medicines on the internet and the VMD Accredited Internet Retailer Scheme (AIRS).
Guidance on the Specific Batch Control (SBC) scheme for release of product on to the UK market.
Guidance on the handling of slurry and manure to help reduce the spread of antibiotic resistant bacteria.
Method of payment for fees charged for the specific activities carried out by the VMD.
Definitive fees charged for applications under Schedule 7 of the Veterinary Medicines Regulations 2013.
Explainer for businesses and persons regulated by the Veterinary Medicines Regulations 2013, as amended, on the transitional provisions included in the amending legislation: the Veterinary Medicines (Amendment etc.) Regulati…
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).